---
title: KCAS Bio vs Swiss BioQuant AG
slug_a: kcasbio
slug_b: swissbioquant
site: cro
review_signal_gate: closed
canonical_path: /compare/kcasbio/swissbioquant
generated_by: BioBM Editorial AI
---

# KCAS Bio vs Swiss BioQuant AG

This comparison is auto-generated by BioBM Editorial AI and intended as an evidence-oriented side-by-side reference.

## Company A

KCAS Bio (kcasbio) is listed for cro. Leading bioanalytical CRO with 45+ years of experience, supporting 315+ approved drugs through bioanalysis, biomarker, immunogenicity, flow cytometry, and clinical kitting services across US, EU, and Australia facilities.

Services: 14. Modalities: 5. Indications: 12. Locations: 7. Certifications: 0. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in services (14).

Review summary: Review summary withheld until site-level review gate opens.

## Company B

Swiss BioQuant AG (swissbioquant) is listed for cro. Bioanalytical CRO offering LC-MS/MS and ligand-binding assay development, validation, and sample analysis for small and large molecules. Work runs in a 21 CFR Part 11 compliant environment, with qPCR support for gene therapy bioanalysis.

Services: 6. Modalities: 6. Indications: 0. Locations: 0. Certifications: 0. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in services (6).

Review summary: Review summary withheld until site-level review gate opens.